Simplify Logo

Full-Time

Director – Quality Assurance

Combination Products

Confirmed live in the last 24 hours

Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

501-1,000 employees

Develops RNAi-based therapies for diseases

Hardware
Biotechnology
Healthcare

Compensation Overview

$180k - $225kAnnually

Senior, Expert

Pasadena, CA, USA + 2 more

Category
QA & Testing
Quality Assurance
Required Skills
Management
Requirements
  • BS or BA Degree in relevant scientific or engineering discipline, and at least 8 years of relevant experience
  • Strong knowledge of FDA regulations (21 CFR Part 820, 21 CFR Parts 210/211), ISO 13485, and other relevant international standards
  • Experience leading QMS implementation, maintenance, and improvement initiatives, including CAPA, change control, and risk management processes
  • Experience in engaging with regulatory authorities
  • Competent knowledge of and ability to use Microsoft Office suite
  • Prior experience with use of an electronic document management system in a regulated environment
  • Ability to follow company procedures, work instructions, and policies
  • Ability to process, synthesize and summarize complex issues
  • Excellent judgment, and analytical, problem-solving skills
  • Work in a safe manner; properly handle materials and chemicals
  • Excellent attention to detail and organizational skills
  • Ability to multi-task and prioritize work tasks with minimal supervision
  • Excellent interpersonal, verbal, and written communication skills
Responsibilities
  • Serve as an internal subject matter expert in the combinational products and primary lead for all relevant elements of QMS and quality aspects of the combinational product development and management
  • Monitor, guide, and ensure internal stakeholders’ decision-making and actions are consistent with cGMPs, QSR, ISO 13485, Good Distribution Practices (GDP), relevant international laws and guidances, and Arrowhead policies and procedures
  • Develop and maintain quality strategy and provide quality guidance to engineering team during all phases of design control, risk management, human factor engineering, process development, verification/validation testing, packaging, and distribution, as well as lifecycle management of design changes and documentation
  • Establish and maintain electronic Design History File (DHF) and Device Master File (DMF), and relevant to the combinational product elements of QMS
  • Champion, maintain, and support continuous improvement to the combination product QMS, monitor and identify areas for improvement and ensure remediation
  • Support development and management of Quality Agreements, external audits of suppliers, and 3rd parties within the Supply Chain
  • Support internal audits, certifications, and facilitate regulatory inspections at Arrowhead and it’s suppliers
  • Prepare and present to management periodic reports and status of regulatory compliance of combination product, QMS, DMF, including the measures and activities to ensure compliance
  • Other duties as assigned
Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

View

Arrowhead Pharmaceuticals develops medicines aimed at treating severe diseases by targeting and silencing specific genes. The company uses RNA interference (RNAi), a natural process that reduces gene expression, to create therapies that can potentially stop or reverse diseases like cystic fibrosis and hepatitis B. Their approach involves a variety of RNA chemistries and effective delivery methods to ensure that the target genes are significantly reduced in activity. Unlike many competitors, Arrowhead focuses specifically on RNAi-based therapies, which allows them to address medical needs that are not met by existing treatments. The goal of Arrowhead Pharmaceuticals is to provide new treatment options for patients suffering from genetic disorders, leveraging their expertise and partnerships to bring these therapies to market.

Company Stage

IPO

Total Funding

$899.9M

Headquarters

Pasadena, California

Founded

2004

Simplify Jobs

Simplify's Take

What believers are saying

  • Arrowhead's recent $450 million funding round provides substantial financial resources to advance its drug pipeline and expand research initiatives.
  • Positive Phase 2 data for plozasiran and the initiation of an Expanded Access Program highlight the company's commitment to addressing unmet medical needs.
  • The company's diversified pipeline, including treatments for cystic fibrosis, hepatitis B, and myotonic dystrophy, offers multiple avenues for success.

What critics are saying

  • The high costs and lengthy timelines associated with drug development could strain Arrowhead's financial resources despite recent funding.
  • Regulatory hurdles and the potential for clinical trial failures pose significant risks to the company's drug approval process.

What makes Arrowhead Pharmaceuticals unique

  • Arrowhead Pharmaceuticals leverages RNA interference (RNAi) technology to target and silence disease-causing genes, setting it apart from traditional pharmaceutical approaches.
  • The company's proprietary TRiM platform enables tissue-specific targeting, enhancing the efficacy and safety of its therapies.
  • Strategic partnerships with major pharmaceutical companies like Takeda bolster Arrowhead's credibility and expand its research capabilities.